Eliot Zhu, MD, PhD

Resident, University of Texas - Southwestern Medical Center
Biography

Mentor: Adam Dupuy, PhD
 

Awarded MD, PhD in Cancer Biology and Medicine in Spring 2023

 

Thesis: 

Modeling therapy resistance to targeted BRAF inhibition in cutaneous melanoma

Awards:

  • 2019-2023 NCI Research Fellowship Award for "Drivers of MAPK-redundant resistance to BRAF inhibition in melanoma" (HHS-NIH)  F30 CA247102
  • 2020 American Skin Association Cohen Family Medical Student Grant "Targetable Drivers of Drug Resistance to BRAF Inhibitors in Melanoma"
  • 2019 Melanoma Research Foundation Grant "Identification of Src family kinases that drive resistance to mutant BRAF inhibition"

Selected Publications:

PubMed

  1. Zhu EY, Dupuy AJ. Machine learning approach informs biology of cancer drug response. BMC Bioinformatics. 2022;23(1):184. PMC9112473
  2. Zhu EY, Schillo JL, Murray SD, Riordan JD, Dupuy AJ. Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma. iScience. 2023;26(10):107805. PMC10582486
Eliot Zhu
Education
MSBS Case Western Reserve University; MD, PhD University of Iowa